SELLAS Life Sciences Group (RXK3.F) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.19
-0.15
-0.1
-0.06

Details

Expected EPS
-0.09824564035
Actual EPS
-0.055263
Surprise EPS
0.04
Surprise Percent
+43.75%

Description

SELLAS Life Sciences Group (RXK3.F) has reported earnings of -0.055263 per share for Q1 2025.

0 Comments

Share your thoughts